Page 4 - One Partnering News Today

/PRNewswire/ -- Lutris Pharma, a clinical stage biopharmaceutical company focused on improving anti-cancer therapies by reducing dose limiting side effects,...

TEL AVIV, Israel, Jan. 4, 2022 /PRNewswire/ -- Lutris Pharma, a clinical stage biopharmaceutical company focused on improving anti-cancer therapies by reducing dose limiting side effects, today

/PRNewswire/ -- Viking Therapeutics, Inc. (Viking) (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for...

Axon Neuroscience to present its 2nd generation COVID-19 monoclonal antibody ACmab1 at the premier biotech eventACmab1 has a superior efficacy and cost profile compared to other antibody therapies in developmentNEW

Berwyn, Pennsylvania--(Newsfile Corp. - June 10, 2021) - Annovis Bio, Inc. (NYSE American: ANVS), ("Annovis" or the "Company"), a clinical-stage drug platform company addressing Alzheimer's disease (AD)

DGAP-News: Axon Neuroscience SE / Key word(s): Miscellaneous Axon Neuroscience to Present at 2021 BIO Digital 10.06.2021 / 13:00 The issuer is solely responsible for the content of this announcement. Axon Neuroscience to Present at 2021 BIO Digital - Axon Neuroscience to present its 2nd generati...

/PRNewswire/ -- Notable Labs Inc., a leader in technology-powered life science with a proprietary platform for predicting patient outcomes and accelerating...

BETHESDA, Md.--(BUSINESS WIRE)--Longhorn Vaccines & Diagnostics, an innovative molecular tool, assay and vaccine development company focused on serving unmet critical needs in both developed and developing nations, announced today that it has been selected to deliver a presentation on the past success and future opp...

San Francisco, CA (PRWEB) June 10, 2021 -- Accelero Biostructures announced today that it has been selected to deliver a company presentation and participate

ESC to Take Part in BIO Digital 2021.